A detailed history of Cresset Asset Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 71,233 shares of VTRS stock, worth $742,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,233
Previous 66,125 7.72%
Holding current value
$742,960
Previous $716,000 18.72%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $57,567 - $69,111
5,108 Added 7.72%
71,233 $850,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $114 - $141
13 Added 0.02%
66,125 $716,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $35,415 - $41,915
3,693 Added 5.92%
66,112 $651,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $439,210 - $501,050
48,693 Added 354.75%
62,419 $622,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $7,746 - $10,322
842 Added 6.54%
13,726 $132,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $185,709 - $246,193
-21,297 Reduced 62.31%
12,884 $143,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $6,207 - $8,147
-732 Reduced 2.1%
34,181 $291,000
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $114,106 - $140,712
11,468 Added 48.91%
34,913 $364,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $26,575 - $41,718
2,709 Added 13.06%
23,445 $254,000
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $4,497 - $5,460
372 Added 1.83%
20,736 $282,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $18,006 - $20,561
1,359 Added 7.15%
20,364 $275,000
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $67,988 - $84,658
-5,242 Reduced 21.62%
19,005 $272,000
Q1 2021

May 12, 2021

SELL
$13.59 - $18.54 $207,573 - $283,179
-15,274 Reduced 38.65%
24,247 $339,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $565,150 - $740,623
39,521 New
39,521 $741,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.